A notable advancement in glucose treatment is emerging with the introduction of tirzepatide at a dosage of 45mg. This updated formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, https://gretauhdr533130.wikiadvocate.com/310241/groundbreaking_approach_tirzepatide_45mg_for_glucose_regulation